-
1تقرير
المصدر: A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03907488Test
-
2تقرير
المصدر: A Phase II Study of Bortezomib (Velcade, PS-341) in Combination With Ifosfamide/Vinorelbine in Pediatric Patients and Young Adults With Refractory/Recurrent Hodgkin Disease
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00381940Test
-
3تقرير
المصدر: A Phase II Study of PS-341 (Bortezomib) in Patients With Relapsed or Refractory Hodgkin's Lymphoma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00082966Test
-
4تقرير
المصدر: A Phase I/II Study of Flavopiridol Administered as a 30-Minute Bolus Followed by a 4-Hour Infusion in Lymphomas and Multiple Myeloma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00112723Test
-
5تقرير
المصدر: A Phase II Trial of Suberoylanilide Hydroxamic Acid (NSC-701852) for Recurrent or Primary Refractory Hodgkin's Lymphoma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00132028Test
-
6تقرير
المصدر: A Randomized Double-Blinded Placebo Controlled Phase II Study of the Anti-CD30 Antibody, SGN-30 (NSC #731636), in Combination With Gemcitabine, Vinorelbine, and Pegylated Liposomal Doxorubicin (GVD) for Patients With Relapsed/Refractory Hodgkin Lymphoma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00337194Test
